Prelude Capital Management’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-24,625
Closed -$537K 1721
2020
Q4
$537K Buy
24,625
+13,553
+122% +$264K 0.01% 703
2020
Q3
$195K Buy
11,072
+5,249
+90% +$97.7K 0.01% 699
2020
Q2
$109K Sell
5,823
-22,332
-79% -$395K 0.01% 926
2020
Q1
$487K Buy
28,155
+2,533
+10% +$53K 0.03% 321
2019
Q4
$541K Sell
25,622
-71,267
-74% -$1.44M 0.02% 540
2019
Q3
$1.9M Buy
+96,889
New +$1.78M 0.09% 199
2019
Q1
Sell
-59,320
Closed -$954K 2015
2018
Q4
$954K Buy
59,320
+12,730
+27% +$201K 0.06% 329
2018
Q3
$695K Buy
+46,590
New +$679K 0.04% 444

Other funds holding MPT

Prelude Capital Management's MPT Position: Q1 2021 in Review

Prelude Capital Management sold out of Medical Properties Trust (MPT) in Q1 2021, closing a stake of 24,625 shares — an estimated $537K sold.

Prelude Capital Management first reported a position in MPT in Q3 2018 and held it in 8 quarters. The position peaked at $1.9M in Q3 2019. 548 funds tracked by Wall St. Rank hold MPT as of Q1 2021.

  • Prelude Capital Management reported no remaining Medical Properties Trust position as of Q1 2021 after selling out during the quarter.
  • Prelude Capital Management sold 24,625 Medical Properties Trust shares in Q1 2021, an estimated $537K.
  • Prelude Capital Management first reported a position in Medical Properties Trust in Q3 2018 and held it in 8 quarters.
  • Prelude Capital Management's Medical Properties Trust position peaked at $1.9M in Q3 2019.
  • 548 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2021.

Based on Prelude Capital Management's 13F filing for Q1 2021, filed 17 May 2021.